Molecular determinants of context-dependent progesterone receptor action in breast cancer
Open Access
- 20 February 2014
- journal article
- review article
- Published by Springer Nature in BMC Medicine
- Vol. 12 (1) , 32
Abstract
The ovarian steroid hormone, progesterone, and its nuclear receptor, the progesterone receptor, are implicated in the progression of breast cancer. Clinical trial data on the effects of hormone replacement therapy underscore the importance of understanding how progestins influence breast cancer growth. The progesterone receptor regulation of distinct target genes is mediated by complex interactions between the progesterone receptor and other regulatory factors that determine the context-dependent transcriptional action of the progesterone receptor. These interactions often lead to post-translational modifications to the progesterone receptor that can dramatically alter receptor function, both in the normal mammary gland and in breast cancer. This review highlights the molecular components that regulate progesterone receptor transcriptional action and describes how a better understanding of the complex interactions between the progesterone receptor and other regulatory factors may be critical to enhancing the clinical efficacy of anti-progestins for use in the treatment of breast cancer.Keywords
This publication has 87 references indexed in Scilit:
- A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cellsNucleic Acids Research, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progressionBreast Cancer Research, 2012
- Role of phosphorylation in progesterone receptor signaling and specificityMolecular and Cellular Endocrinology, 2012
- ck2-Dependent Phosphorylation of Progesterone Receptors (PR) on Ser81 Regulates PR-B Isoform-Specific Target Gene Expression in Breast Cancer CellsMolecular and Cellular Biology, 2011
- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary glandProceedings of the National Academy of Sciences, 2010
- Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cellsProceedings of the National Academy of Sciences, 2009
- Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenograftsProceedings of the National Academy of Sciences, 2008
- Progesterone Receptors Upregulate Wnt-1 To Induce Epidermal Growth Factor Receptor Transactivation and c-Src-Dependent Sustained Activation of Erk1/2 Mitogen-Activated Protein Kinase in Breast Cancer CellsMolecular and Cellular Biology, 2007
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003